The Valley Desk

NCT02434354 · Interventional trial

A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Overall registry status Completed

Phase 1

Conditions Malignant Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov